| 发明名称 |
Method for identifying at risk cardiovascular disease patients |
| 摘要 |
The invention provides a method for identifying patients with normal NCEP lipid levels who are in need of treatment for cardiovascular disease comprising measuring one or more LDL or HDL particle subclass levels and identifying abnormal LDL or HDL subclass levels. LDL III a+b and HDL 2b are preferred subclasses.
|
| 申请公布号 |
US2005042761(A1) |
申请公布日期 |
2005.02.24 |
| 申请号 |
US20040959656 |
申请日期 |
2004.10.06 |
| 申请人 |
BERKELEY HEARTLAB, INC. |
发明人 |
SHEWMAKE DAVID;RUDERMAN FRANK;BOGGESS CHRISTOPHER |
| 分类号 |
G01N33/92;(IPC1-7):G01N33/92 |
主分类号 |
G01N33/92 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
